Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimising Treatment With Tumour Necrosis Factor Inhibitors In Rheumatoid Arthritis (OPTTIRA)
2010-020738-24Phase 4Completed
- Sponsor
- King's College London
- Start
- Aug 2010
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of etanercept and adalimumab in rheumatoid arthritis (RA) (3 arms), sponsored by King's College London. Primary endpoint: Development of flares. Started Aug 2010; status: completed.
02
Drugs
etanerceptadalimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-020738-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020738-24.